Insider Transactions in Q4 2024 at Replimune Group, Inc. (REPL)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 16
2024
|
Sushil Patel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.72%
|
$120,000
$12.42 P/Share
|
Nov 18
2024
|
Christopher Sarchi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,207
-5.64%
|
$52,070
$10.78 P/Share
|
Nov 18
2024
|
Konstantinos Xynos Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,246
-6.19%
|
$72,460
$10.78 P/Share
|